Navigating Federal Workforce Reduction and Regulatory Reform

This chapter examines the consequences of minimizing the federal workforce, particularly how it affects the FDA's drug approval process and subsequent implications for public health. It argues for a careful balance of regulation that promotes efficiency and economic growth, while also addressing the inefficiencies and complexities inherent in current bureaucratic systems.